Shaheen E Lakhan, MD, PhD, FAAN

Shaheen E Lakhan, MD, PhD, FAAN has a long and varied work experience. In 2020, they became the Chief Medical Officer and Senior Vice President of Research & Development at Click Therapeutics, Inc., where they direct the planning and advancement of the digital therapeutics pipeline across multiple therapeutic areas. Shaheen E is also an Independent Board Director at SpineThera, a clinical stage pharmaceutical company, since 2022. In the same year, they became an Adjunct Clinical Professor at Morehouse School of Medicine. From 2016 to 2022, they were a Clinical Professor of Neurology and Clinical Associate Professor of Neurology at Western University of Health Sciences. In 2022, they became a Neurology Consultant at Mount Auburn Hospital. In 2021, they became a Board Member at Riverside Community Care, a nonprofit, community-based, brain-healthcare system. In 2019, they became a Board Member at the Center for Collaborative Education. Shaheen E has also been an Adjunct Professor of Neuroscience at Virginia Tech since 2017 and Executive Director at the Global Neuroscience Initiative Foundation since 2003. Finally, since 2019, they have been a Neurology and Pain Management Consultant at Cambridge Health Alliance.

Shaheen E Lakhan, MD, PhD, FAAN has an extensive education history. Shaheen E obtained their MD from the Technion - Israel Institute of Technology in 2009, cum laude. Shaheen E then earned their PhD in Biological Sciences from UCN European Programmes in 2008, and their MEd in Education Technology from the University of Southern Queensland in 2006. In 2010, they completed their residency in Neurology at the Cleveland Clinic Lerner College of Medicine, and in 2014 they completed a Clinical Fellowship in Pain Medicine at the Massachusetts General Hospital. In 2019, they completed a Postgraduate Course in Clinical Pharmacology, Drug Development & Regulation at Tufts University School of Medicine. Additionally, they have obtained several certifications, including a Virginia Medical License in 2017, Board Certification in Pain Medicine in 2016, Board Certification in Neurology in 2015, a Massachusetts Medical License in 2014, a California Medical License in 2012, BLS-ACLS Certification in 2009, and Associate Fellow status with the American Association for Clinical Chemistry in 2007.